EligibleTrials

A Long-term Follow-up Study in Patients Who Received BEAM-101

Recruiting · NCT07373639 · Observational (researchers observe without assigning treatment) · Lead sponsor: Beam Therapeutics Inc.

View the official record on ClinicalTrials.gov →
Sickle Cell Disease

Interventions studied

Long-Term Follow-up Study of patients who received BEAM-101

What this trial is about

This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to participate in this LTFU study prior to completing Study BTX-AUT-001. Patients who enter into this study will be followed for 13 years (a total of 15 years after receiving BEAM-101).

Who can take part

Age range
14 Years to 37 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

17 locations listed across 15 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.